These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15346332)

  • 21. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.
    Semenova VA; Steward-Clark E; Stamey KL; Taylor TH; Schmidt DS; Martin SK; Marano N; Quinn CP
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):919-23. PubMed ID: 15358653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
    Ghosh N; Gunti D; Lukka H; Reddy BR; Padmaja J; Goel AK
    Indian J Med Res; 2015 Aug; 142(2):196-204. PubMed ID: 26354217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women.
    Zhang Y; Martin SW; Rose CE; Biagini RE; Franzke LH; Smith JP; Sammons DL; Robertson SA; McNeil MM
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1060-7. PubMed ID: 18781705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM; Sirota LA; Wagner LD; Menzies SL; Arciniega JL
    Vaccine; 2009 Jul; 27(33):4537-42. PubMed ID: 19501205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
    J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
    Steiniger SC; Altobell LJ; Zhou B; Janda KD
    Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.
    Boyer AE; Quinn CP; Beesley CA; Gallegos-Candela M; Marston CK; Cronin LX; Lins RC; Stoddard RA; Li H; Schiffer J; Hossain MJ; Chakraborty A; Rahman M; Luby SP; Shieh WJ; Zaki S; Barr JR; Hoffmaster AR
    J Infect Dis; 2011 Nov; 204(9):1321-7. PubMed ID: 21908727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
    Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(22):482. PubMed ID: 12064454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.
    Ndumnego OC; Crafford J; Beyer W; van Heerden H
    BMC Vet Res; 2013 Dec; 9():265. PubMed ID: 24373579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses.
    Midha S; Bhatnagar R
    Eur J Immunol; 2009 Jan; 39(1):159-77. PubMed ID: 19130551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.
    Crotty S; Aubert RD; Glidewell J; Ahmed R
    J Immunol Methods; 2004 Mar; 286(1-2):111-22. PubMed ID: 15087226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK; Boehm R; Beyer W
    Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.